The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
The approval makes mFLUSIVA Moderna’s fourth FDA-cleared product and the first messenger RNA-based flu vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results